Silo Pharma’s QwikAgents Joins AMD AI Developer Program
The move gives the startup cloud credits and development tools that Silo says could speed testing and scaling of a persistent AI-agent platform.
Overview
- Silo Pharma announced on Tuesday that its wholly owned subsidiary QwikAgents was accepted into Advanced Micro Devices’ AI Developer Program, a step the company says will support platform development.
- Membership provides access to AMD Developer Cloud credits, AI development tools, training resources and technical support intended for hosting, optimization, benchmarking and possible model training.
- QwikAgents is building a persistent AI-agent service with features the company describes as persistent memory, smart model routing, encrypted backups, browser automation and starter plans beginning at $14 per month.
- The announcement prompted an immediate market reaction with Silo Pharma shares falling about 4.92% intraday and stabilizing near $5.02, reflecting investor caution about the company’s shift into software.
- The effort represents a diversification from Silo’s core biopharmaceutical work and remains forward-looking; the company’s press release warns that technical, commercial and competitive risks could affect outcome and the next milestones to watch are benchmarking results and scalable deployments.